Women's Health News: Breaking Women's Health News, Comments and Articles. - Page: 2

12:16 EST 20th December 2014 | BioPortfolio

Women's Health News - Page: 2Twitter RSS

Read the latest Women's Health News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Women's Health.

Search or Follow Our Women's Health - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Women's Health - Page: 2 News.
You can also follow our Women's Health - Page: 2 news stories on Twitter: @womens_womens

Showing "women breast cancer menopause Pregnancy" News Articles 26 to 50 of 23,000+

Friday 19th December 2014

AHF: CDC’s Latest STD Report Confirms “Syphilis Explosion”

California ranks No. 1 in syphilis cases; nationwide infections increase by ten percent The rate of primary and secondary syphilis infections last year was the highest recorded since 1996, the Centers for Disease Control and Prevention (CDC) announced this week with the release of their 2013 STD Surveillance report. In 2013, there were 17,357 confirmed...

Putting the Breaks on Cancer

A study led by the University of Dundee, in collaboration with the University of Bath, has uncovered an important role played by a tumor suppressor gene, helping scientists to better understand how it combats the effects of mutations which drive cancer development. The research, published in Proceedings of the National Academy of Sciences (PNAS) USA, shows how an enzyme called Dual-speci

AstraZeneca's ovarian cancer drug gets U.S. approval

(Reuters) - AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.

Expanded Study Confirms that Lyme Disease May Be Sexually Transmitted

International team of scientists led by Union Square Medical Associates finds evidence for sexual transmission. San Francisco, California (PRWEB) December 19, 2014 An expanded study confirms that Lyme disease may be sexually transmitted. The study was published in the open access journal F1000Research (http://f1000research.com/articles/3-309/v1). Lyme disease is a tickborne infection caused by ...

UPDATE 1-AstraZeneca's ovarian cancer drug gets U.S. approval

Dec 19 (Reuters) - AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.

Combo Drug Therapy Doubles Positive Effect for Women with Breast Cancer

In a groundbreaking study that offers new hope for women with advanced breast cancer, researchers from UCLA’s Jonsson Comprehensive Cancer Center have published final clinical trial results that showed the amount of time women with advanced breast cancer were on treatment without their cancer worsening was effectively doubled when they took the experimental drug palbociclib. An investigational ...

ADHD med prescriptions for young women have jumped 85 percent in just five years – overdiagnoses?

Drugs like Adderall are sometimes being abused as stimulants for people who don’t actually have ADHD, especially by college students. But there’s more to the story. Whether it’s overdiagnoses or...

AstraZeneca’s Olaparib Clears FDA For Later Therapy Line In Ovarian Cancer

AstraZeneca’s Lynparza was rejected as a maintenance therapy after second-line treatment by an FDA advisory committee, but landed accelerated approval for heavily pretreated relapsed patients, based on data not considered in the initial advisory co...

Cancer Treatment Costs Weigh Heavily on Patients, Study Finds

FRIDAY, Dec. 19, 2014 -- The cost of cancer treatment can cause financial stress that threatens patients' well-being, a new study finds. Researchers examined data from 1,000 people in the United States who had been diagnosed with colorectal or lung.....

AbbVie Receives U.S. FDA Approval of VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C

NORTH CHICAGO, Ill., Dec. 19, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved AbbVie's (NYSE:ABBV) VIEKIRA PAK™, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis. VIEKIRA PAK is the only FDA-approv...

FDA grants accelerated approval to AstraZeneca's ovary cancer drug

(Reuters) - AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after it was approved by the European Commission.

Exact Sciences nets $102mm through follow-on

Molecular diagnostics firm Exact Sciences Corp. netted $102mm through the public sale of 4mm shares at $25.75. Some of the proceeds will fund commercialization activities surrounding Cologuard, the company's stool DNA-based colorectal cancer screenin...

Roche's Breast Cancer Drug Trial Fails

SOUTH SAN FRANCISCO (dpa-AFX) - Swiss drug maker Roche Holding AG (RHHBY.PK) on Friday said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an e...

Albert Einstein College of Medicine and Montefiore Health System Name New Chair of Obstetrics & Gynecology and Women's Health

BRONX, N.Y., Dec. 19, 2014 /PRNewswire-USNewswire/ -- Sharmila Makhija, M.D., M.B.A., has been named professor and chair of the Department of Obstetrics & Gynecology and Women's Health at Albert Einstein College of Medicine and Montefiore Health System. An internationally-recognized expert in cancer prevention, she assumes her new position on April 1, 2015. Dr. Makhija joins Einstein and ...

AstraZeneca cancer drug, companion test approved

U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC.

Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVE® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Pfizer has received EU marketing authorization for DUAVIVE® (conjugated estrogens/bazedoxifene (BZA/CE)) from the European Commission. In the EU, DUAVIVE™ is indicated for the treatment of estrogen deficiency symptoms in postmenopausal women with a uterus (with at least 12 mon...

Roche builds personalized healthcare in China

In November, China's state food and drug administration approved Roche's cobas KRAS mutation test for the Chinese market. Cobas KRAS test is a method to detect metastatic colorectal cancer that is not likely to respond to anti-EGFR monoclonal antibod...

LYNPARZA(TM) Approved By The US Food and Drug Administration For The Treatment Of Advanced Ovarian Cancer In Patients With Germline BRCA-mutations

WILMINGTON, Del., Dec. 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZA™ (olaparib) capsules. LYNPARZA is the first poly ADP-ribose polymerase (PARP) inhibitor indicated as monotherapy in patients with deleterious or suspected deleterious germline BRCA-mutated (as detected by an FDA-approved test) advanced ovarian ...

Babies in Your 30s? Don’t Worry, Your Great-Grandma Did It Too

(Medical Xpress) – And technologies such as IVF, egg donation and egg freezing allow women to beat the biological clock, freeing them from the tyranny of their own biology. A recent Newsweek headline, for example, announced that women can now &...

Early exposure to antidepressants affects adult anxiety, serotonin transmission

Early developmental exposure to two different antidepressants, Prozac and Lexapro, has been studied by researchers in a mouse model that mimics human third trimester medication exposure. They found that, although these serotonin-selective reuptake in...

Final Agenda Released for Oxford Global’s 4th Annual Clinical Development and Trials Asia Congress

Oxford Global Conferences are delighted to announce the release of the final agenda for the upcoming 4th Annual Clinical Development & Trials Asia Congress and co-located 5th Annual Pharma R&D World Asia Congress, taking place on the 27th & 28th January 2015 in Shanghai, China. Attended by over 170 industry leaders, the 4th Annual Clinical Development and Trials Asia Congress will of...

Olaparib Wins FDA Approval for Ovarian Cancer

(MedPage Today) -- But could be yanked if confirmatory trials fail.

What is value in cancer care? It depends.

Value. A simple word with lots of meanings, all of which depend on the context of the moment. Value in health care — especially in cancer care — is certainly no exception. What is undeniable is that we are seeing an increasing clamor about value in cancer treatment. And one person’s value is clearly another […]

Skincare & Beauty Stocking Stuffers for All Ages – Presented by Skincare-News.com

It can be challenging to find stocking stuffers for loved ones. The latest article from Skincare-News offers a handy guide for giving skincare and beauty gifts to family members, young and old. Sacramento, CA (PRWEB) December 19, 2014 It can be challenging enough for consumers to find the perfect Christmas gifts for their loved ones. So when it comes to buying stocking stuffers, many people give ...

'Surveillance' may be safest for low-risk prostate cancer

(Reuters Health) - Among men whose low-risk prostate cancer was managed with so-called active surveillance for up to 15 years, just 1.5 percent died of the cancer, according to new data from a Canadian study.


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks